Hepatitis B virus-related membranous nephropathy treated with entecavir.
Ikee
Ryota
R
Department of Nephrology and Kidney and Dialysis Centre, Shonan Kamakura General Hospital, Yamasaki, Kamakura, Japan.
Ishioka
Kunihiro
K
Oka
Machiko
M
Maesato
Kyoko
K
Moriya
Hidekazu
H
Hidaka
Sumi
S
Ohtake
Takayasu
T
Kobayashi
Shuzo
S
D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006510:Hepatitis B Antibodies / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D011507:Proteinuria / Q000188:drug therapy / Q000821:virology; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006513:Hepatitis B e Antigens; C413685:entecavir; D006147:Guanine; D003404:Creatinine